专利号:US-12351573-B2 优先权日:2019-05-09 标 题:Compounds for use in synthesis of peptidomimetics 发明人:AL-ABED YOUSEF; CHENG KAI FAN 权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 摘要:Synthesis of O-benzotriazole and O-imidazole synthons are described. Uses of synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the synthons and uses of azapeptides and other peptidomimetics are also described.
专利号:US-2023159450-A1 优先权日:2020-05-08 标 题 :Dimers for use in synthesis of peptidomimetics 发明人:AL-ABED YOUSEF; ALTITI AHMAD 权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 摘要:Dimers for use in synthesis of peptidomimetics are described. Uses of dimers as synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the dimers and uses of azapeptides and other peptidomimetics are also described.
专利号:US-2020354404-A1 优先权日:2019-05-09 标 题 :Peptidomimetic agents, synthesis and uses thereof 发明人:AL-ABED YOUSEF 权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 摘要:Compounds for use in synthesis of peptidomimetic agents; synthesis of peptidomimetic agents; peptidomimetic diagnostic and therapeutic agents; and uses of the compounds and peptidomimetic agents in drug discovery, diagnosis, prevention and treatment of diseases are described.
专利号:US-2005164912-A1 优先权日:2003-12-31 标 题:Methods for recovering cleaved peptide from a support after solid phase synthesis 发明人:BIGELOW ROGER D; CAIN ROBERT O 摘要:Methods for the solid phase synthesis of peptides and peptide intermediates, in particular methods involving recovering peptides from resin supports at excellent yield. In this invention, an alternating at least partially repeating cycle of shrinking and swelling treatments are used. Each shrinking or swelling part of a cycle may involve one or more washes. The process provides excellent recovery of peptide in a very efficient manner in terms of the number of individual washes and the total volume of wash reagents used.
专利号:US-9695214-B2 优先权日:2013-03-15 标 题 :Solid phase peptide synthesis processes and associated systems 发明人:SIMON MARK DAVID; PENTELUTE BRADLEY L; ADAMO ANDREA; HEIDER PATRICK LOUIS; JENSEN KLAVS F 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:Systems and processes for performing solid phase peptide synthesis are generally described. Solid phase peptide synthesis is a known process in which amino acid residues are added to peptides that have been immobilized on a solid support. In certain embodiments, the inventive systems and methods can be used to perform solid phase peptide synthesis quickly while maintaining high yields. Certain embodiments relate to processes and systems that may be used to heat, transport, and/or mix reagents in ways that reduce the amount of time required to perform solid phase peptide synthesis.
专利号:US-2005165215-A1 优先权日:2003-12-31 标 题 :Peptide synthesis and deprotection using a cosolvent 发明人:BIGELOW ROGER D; SCHWINDT MARK A; WITHERS GREGORY P 摘要:The invention provides methods for synthesizing peptides, which include taking an organic solvent having non-resin bound protected peptide and performing a deprotection reaction on the non-resin bound protected peptide. In these methods it is not required that the peptide is dried immediately before providing to the deprotection reaction. Also provided are methods of synthesizing peptides, wherein a protected peptide is formed in a solution phase reaction, dissolved into an organic solvent, and then introduced into a deprotection reaction. Also provided are methods of synthesizing peptides, wherein a non-resin bound protected peptide is concentrated in an organic solvent prior to being subject to a deprotection reaction.
1: Mujtaba MA, Elsiesy H, Faiz S, Hussain SA, Gamilla-Crudo AKN, Karim A, Khan MI, Khattak MW, Zafar Z, Kueht M, Jamil K. Defining Renal Recovery in Patients With Hepatorenal Syndrome-Acute Kidney Injury: Experience From North American Studies. JGH Open. 2024 Dec 10;8(12):e70058. doi: 10.1002/jgh3.70058. 2: Law JH, Kow AW. Prediction and Management of Small-for-Size Syndrome in Living Donor Liver Transplantation. Clin Mol Hepatol. 2024 Dec 10. doi: 10.3350/cmh.2024.0870. Epub ahead of print. 119(9):1943. doi: 10.14309/ajg.0000000000002841. Epub 2024 May 21. 85(11):1-13. doi: 10.12968/hmed.2024.0606. Epub 2024 Nov 25. 30(43):4602-4608. doi: 10.3748/wjg.v30.i43.4602. 7: Nadim MK, Forni LG, Ostermann M; ADQI 29/ICA panel. Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Author's reply. Intensive Care Med. 2024 Nov 21. doi: 10.1007/s00134-024-07720-0. Epub ahead of print. 69(11):4313. doi: 10.1007/s10620-024-08662-9. Epub 2024 Oct 17. 12(10):e9141. doi: 10.1002/ccr3.9141.
合成参考文献
参考文献:10.1186/1471-2482-11-15 摘要:Groenewold MD, Gribnau AJ, Ubbink DT. Topical haemostatic agents for skin wounds: a systematic review. BMC Surg. 2011 Jul 12;11():15. 参考文献:10.3350/kjhep.2011.17.2.130 摘要:Kim DJ, Kang HS, Choi HS, Cho HJ, Kim ES, Keum B, An H, Kim JH, Seo YS, Kim YS, Yim HJ, Jeen YT, Lee HS, Um SH, Kim CD, Ryu HS. Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. Korean J Hepatol. 2011 Jun;17(2):130–8. 参考文献:10.2174/1874613601105010059 摘要:Álvarez Díaz H, Mariño Callejo A, García Rodríguez JF. Non-Cirrhotic Portal Hypertension in Human Immunodeficiency Virus-Infected Patients: A New Challenge in Antiretroviral Therapy Era. TOAIDJ. 2011 Jun 29;05(1):59–61. doi: 10.2174/1874613601105010059.